In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Aethlon Medical, Inc.. Trade Record

NASDAQ:AEMD Aethlon Medical, Inc. stock gains 6.26% Exit Feb 7, 2017 a Trade Record by priceseries

Trade Chart
Trade Chart AEMD Jan 30, 2017, priceSeries
About Aethlon Medical, Inc.

Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in cancer, infectious diseases, and other life-threatening conditions in the United States. The company develops Aethlon Hemopurifier, a medical device, which targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. Its Aethlon Hemopurifier addresses antiviral drug-resistance in hepatitis-C virus and human immunodeficiency virus infected individuals; serves as a countermeasure against viral pathogens not addressed by drug or vaccine therapies; and represents the therapeutic strategy to address cancer promoting exosomes. The company is also involved in developing exosome-based products to diagnose and monitor neurological disorders and cancer; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection that often results in the death of combat-injured soldiers. Aethlon Medical, Inc. was founded in 1991 and is based in San Diego, California.

Trade Information
Trade Type
LONG
ReliabilityScore™
73.71
Entry Date
Jan 30, 2017
Entry Price
4.00
Sell Date
Feb 7, 2017
Sell Price
4.25
Net Gain
6.26%
Hold Time
6 Trading Days